Catalyst overview
Research summary
This catalyst tracks a Phase 1/2 data readout for MDX2004 in Advanced cancers. The expected timing is based on the latest available company guidance and may change.
07/27/26:- MDX2004 Phase 1 enrollment continues; initial data expected H1 2027.
Verification
Confirm timing and program details against the company announcement or filing.